Found: 121
Select item for more details and to access through your institution.
Percutaneous superfine-needle aspiration biopsy of intrathoracic lesions guided by simulator.
- Published in:
- Journal of Surgical Oncology, 1989, v. 40, n. 2, p. 135, doi. 10.1002/jso.2930400215
- By:
- Publication type:
- Article
Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5- Aza-d C and radiation on cervical cancer cells.
- Published in:
- Cell Biochemistry & Function, 2017, v. 35, n. 8, p. 488, doi. 10.1002/cbf.3282
- By:
- Publication type:
- Article
A novel image deep learning–based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.
- Published in:
- European Radiology, 2024, v. 34, n. 3, p. 2048, doi. 10.1007/s00330-023-10026-2
- By:
- Publication type:
- Article
Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules.
- Published in:
- Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1663666
- By:
- Publication type:
- Article
Emerging therapies for non-small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0731-8
- By:
- Publication type:
- Article
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2023, v. 64, n. 6, p. 1, doi. 10.1093/ejcts/ezad373
- By:
- Publication type:
- Article
Do-not-resuscitate orders among advanced-stage Chinese lung cancer patients who died in hospital.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 3, p. 635, doi. 10.1007/s00520-014-2405-y
- By:
- Publication type:
- Article
Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer.
- Published in:
- Pathology & Oncology Research, 2009, v. 15, n. 4, p. 651, doi. 10.1007/s12253-009-9167-8
- By:
- Publication type:
- Article
A novel small‐animal locomotor activity recording device for biological clock research.
- Published in:
- Animal Models & Experimental Medicine, 2024, v. 7, n. 1, p. 71, doi. 10.1002/ame2.12381
- By:
- Publication type:
- Article
Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359241234504
- By:
- Publication type:
- Article
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229435
- By:
- Publication type:
- Article
Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231193726
- By:
- Publication type:
- Article
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818
- By:
- Publication type:
- Article
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138380
- By:
- Publication type:
- Article
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 10, p. 3808, doi. 10.1245/s10434-020-08400-1
- By:
- Publication type:
- Article
KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 4, p. 1381, doi. 10.1245/s10434-012-2754-z
- By:
- Publication type:
- Article
Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 380, doi. 10.1111/ajco.12513
- By:
- Publication type:
- Article
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, n. 3, p. 232, doi. 10.1111/j.1743-7563.2012.01518.x
- By:
- Publication type:
- Article
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 477, doi. 10.1007/s10637-020-01010-4
- By:
- Publication type:
- Article
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 267, doi. 10.1007/s10147-019-01552-5
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 3, p. 160, doi. 10.3816/CLC.2010.n.020
- By:
- Publication type:
- Article
Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients.
- Published in:
- Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00199-z
- By:
- Publication type:
- Article
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6
- By:
- Publication type:
- Article
In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134733
- By:
- Publication type:
- Article
Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069104
- By:
- Publication type:
- Article
Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical Treatment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060157
- By:
- Publication type:
- Article
Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2013, v. 270, n. 3, p. 1027, doi. 10.1007/s00405-012-2241-y
- By:
- Publication type:
- Article
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2257, doi. 10.1007/s00262-023-03412-8
- By:
- Publication type:
- Article
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1261, doi. 10.1007/s00262-022-03330-1
- By:
- Publication type:
- Article
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 881, doi. 10.1007/s00262-022-03288-0
- By:
- Publication type:
- Article
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1393, doi. 10.1007/s00262-021-03091-3
- By:
- Publication type:
- Article
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 3, p. 471, doi. 10.1007/s00262-017-2098-4
- By:
- Publication type:
- Article
Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00470-z
- By:
- Publication type:
- Article
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00465-w
- By:
- Publication type:
- Article
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09762-1
- By:
- Publication type:
- Article
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 302, doi. 10.3390/cancers15010302
- By:
- Publication type:
- Article
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
- Published in:
- Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z
- By:
- Publication type:
- Article
ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules—A Large Study of 2022 Cases in China.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7400, doi. 10.1245/s10434-023-14009-x
- By:
- Publication type:
- Article
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article